This topic contains a solution. Click here to go to the answer

Author Question: One basic element of a token economy is a list of backup reinforcers, including a. who is ... (Read 244 times)

Deast7027

  • Hero Member
  • *****
  • Posts: 538
One basic element of a token economy is a list of backup reinforcers, including
 
  a. who is eligible for which contingencies.
  b. a schedule for when each contingency is active.
  c. variations in schedules of reinforcement.
  d. the token cost of each available item.

Question 2

One basic element of a token economy is a list of acceleration and deceleration target behaviors, including
 
  a. to whom each item applies.
  b. under what conditions the rules are in effect.
  c. the specific token-behavior contingencies.
  d. end-of-therapy performance expectations.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

abctaiwan

  • Sr. Member
  • ****
  • Posts: 355
Answer to Question 1

d

Answer to Question 2

c




Deast7027

  • Member
  • Posts: 538
Reply 2 on: Jun 22, 2018
Wow, this really help


blakcmamba

  • Member
  • Posts: 335
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library